(ARDX) Ardelyx - Performance -54.9% in 12m
Compare ARDX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-44.01%
#53 in Group
Rel. Strength
15.57%
#6718 in Universe
Total Return 12m
-54.86%
#90 in Group
Total Return 5y
-55.14%
#57 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.08
52th Percentile in Group
FCF Yield -4.95%
71th Percentile in Group
12m Total Return: ARDX (-54.9%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ARDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARDX
| Total Return (including Dividends) | ARDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -18.83% | 2.77% | 5.69% |
| 3 Months | -34.42% | -14.21% | -6.49% |
| 12 Months | -54.86% | -14.88% | 9.72% |
| 5 Years | -55.14% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ARDX | XBI | S&P 500 |
| 1 Month | -29.0% | 57% | 89.4% |
| 3 Months | -67.0% | -82.3% | -72% |
| 12 Months | -76.3% | -53.1% | 49.3% |
| 5 Years | 2.60% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #183 | -21.0% | -23.2% |
| 3 Month | #119 | -23.6% | -29.9% |
| 12 Month | #89 | -47.0% | -58.9% |
| 5 Years | #57 | -39.0% | -78.4% |
FAQs
Does ARDX Ardelyx outperforms the market?
No,
over the last 12 months ARDX made -54.86%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months ARDX made -34.42%, while XBI made -14.21%.
Over the last 3 months ARDX made -34.42%, while XBI made -14.21%.
Performance Comparison ARDX vs Indeces and Sectors
ARDX vs. Indices ARDX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.23% | -24.5% | -20.9% | -64.6% |
| US NASDAQ 100 | QQQ | -3.50% | -26.2% | -21.3% | -65.7% |
| US Dow Jones Industrial 30 | DIA | -3.12% | -21.5% | -19.9% | -61.1% |
| German DAX 40 | DAX | -3.68% | -33.9% | -46.5% | -79.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.46% | -21.7% | -20.1% | -61.2% |
| Hongkong Hang Seng | HSI | -6.11% | -33.7% | -30.4% | -63.1% |
| India NIFTY 50 | INDA | 0.47% | -22.0% | -22.8% | -56.9% |
| Brasil Bovespa | EWZ | -6.26% | -30.5% | -30.1% | -48.6% |
ARDX vs. Sectors ARDX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.60% | -25.3% | -27.1% | -75.2% |
| Consumer Discretionary | XLY | -4.65% | -25.5% | -18.7% | -69.7% |
| Consumer Staples | XLP | -2.37% | -19.5% | -27.8% | -62.1% |
| Energy | XLE | -5.48% | -23.3% | -14.9% | -45.8% |
| Financial | XLF | -3.93% | -25.7% | -26.8% | -76.4% |
| Health Care | XLV | 0.87% | -15.8% | -15.7% | -48.9% |
| Industrial | XLI | -4.16% | -27.1% | -21.9% | -65.2% |
| Materials | XLB | -3.39% | -23.9% | -16.9% | -48.8% |
| Real Estate | XLRE | -2.44% | -25.7% | -23.3% | -68.4% |
| Technology | XLK | -4.07% | -28.5% | -18.6% | -61.0% |
| Utilities | XLU | -3.95% | -24.0% | -28.7% | -70.9% |
| Aerospace & Defense | XAR | -3.41% | -28.0% | -30.2% | -80.8% |
| Biotech | XBI | 4.49% | -21.6% | 0.16% | -40.0% |
| Homebuilder | XHB | -2.87% | -24.4% | -7.27% | -46.0% |
| Retail | XRT | -3.29% | -25.0% | -14.6% | -48.6% |